| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/27/2023 | -4.3% | Macquarie | → $5.12 | Upgrades | Underperform → Neutral |
| 05/17/2023 | 86.92% | Benchmark | → $10 | Reiterates | Buy → Buy |
| 05/17/2023 | 19.63% | HSBC | $8 → $6.4 | Maintains | Hold |
| 05/17/2023 | 49.53% | Credit Suisse | $7.7 → $8 | Upgrades | Neutral → Outperform |
| 04/06/2023 | — | OTR Global | Upgrades | Negative → Mixed | |
| 04/06/2023 | — | OTR Global | Upgrades | Negative → Mixed | |
| 03/06/2023 | 86.92% | Goldman Sachs | → $10 | Upgrades | Neutral → Buy |
| 03/02/2023 | 68.22% | B of A Securities | $4.7 → $9 | Upgrades | Neutral → Buy |
| 02/23/2023 | 49.53% | HSBC | $5 → $8 | Maintains | Hold |
| 01/19/2023 | -4.67% | Morgan Stanley | $2.8 → $5.1 | Upgrades | Underweight → Equal-Weight |
| 01/09/2023 | -8.41% | Goldman Sachs | $4.4 → $4.9 | Maintains | Neutral |
| 11/23/2022 | -17.76% | Goldman Sachs | $5.1 → $4.4 | Maintains | Neutral |
| 10/14/2022 | -25.23% | Citigroup | $6.5 → $4 | Maintains | Buy |
| 09/07/2022 | 30.84% | JP Morgan | → $7 | Assumes | → Overweight |
| 09/01/2022 | -10.28% | UBS | → $4.8 | Upgrades | Neutral → Buy |
| 08/31/2022 | 12.15% | Benchmark | $7 → $6 | Maintains | Buy |
| 08/23/2022 | -47.66% | Macquarie | → $2.8 | Initiates Coverage On | → Underperform |
| 05/27/2022 | 30.84% | Benchmark | → $7 | Upgrades | Hold → Buy |
| 05/16/2022 | 49.53% | JP Morgan | $2 → $8 | Upgrades | Underweight → Overweight |
| 03/14/2022 | -62.62% | JP Morgan | → $2 | Downgrades | Overweight → Underweight |
| 03/02/2022 | — | JP Morgan | Upgrades | Neutral → Overweight | |
| 01/10/2022 | — | OTR Global | Downgrades | Mixed → Negative | |
| 12/28/2021 | — | Benchmark | Initiates Coverage On | → Hold | |
| 11/02/2021 | — | UBS | Downgrades | Buy → Neutral | |
| 10/05/2021 | — | OTR Global | Downgrades | Positive → Mixed | |
| 08/13/2021 | 255.14% | Keybanc | $26 → $19 | Maintains | Overweight |
| 07/07/2021 | — | OTR Global | Upgrades | Mixed → Positive | |
| 05/19/2021 | 199.07% | CLSA | $25.5 → $16 | Upgrades | Underperform → Outperform |
| 05/19/2021 | 385.98% | Keybanc | $30 → $26 | Maintains | Overweight |
| 05/06/2021 | 180.37% | JP Morgan | $18 → $15 | Upgrades | Underweight → Neutral |
| 04/29/2021 | 217.76% | Credit Suisse | $18.5 → $17 | Upgrades | Underperform → Neutral |
| 02/23/2021 | 460.75% | Keybanc | → $30 | Upgrades | Sector Weight → Overweight |
| 01/19/2021 | 212.15% | Credit Suisse | → $16.7 | Downgrades | Neutral → Underperform |
| 01/13/2021 | 303.74% | HSBC | → $21.6 | Downgrades | Buy → Hold |
| 01/05/2021 | 329.91% | New Street Research | → $23 | Upgrades | Neutral → Buy |
| 12/23/2020 | 333.64% | CMB International | → $23.2 | Initiates Coverage On | → Buy |
| 06/25/2020 | — | Oppenheimer | Downgrades | Outperform → Perform | |
| 04/14/2020 | 329.91% | Oppenheimer | → $23 | Initiates Coverage On | → Outperform |
| 03/02/2020 | 329.91% | JP Morgan | $22 → $23 | Maintains | Neutral |
| 12/02/2019 | 273.83% | Morgan Stanley | → $20 | Initiates Coverage On | → Equal-Weight |
| 11/11/2019 | — | UBS | Upgrades | Neutral → Buy | |
| 11/07/2019 | — | CLSA | Downgrades | Outperform → Underperform | |
| 09/12/2019 | — | Bernstein | Upgrades | Underperform → Market Perform | |
| 08/20/2019 | — | Credit Suisse | Downgrades | Outperform → Neutral | |
| 08/20/2019 | 292.52% | CLSA | $26.5 → $21 | Downgrades | Buy → Outperform |
| 08/20/2019 | — | China Renaissance | Downgrades | Buy → Hold | |
| 08/16/2019 | 161.68% | JP Morgan | → $14 | Initiates Coverage On | → Underweight |
| 08/05/2019 | 307.48% | Jefferies | → $21.8 | Initiates Coverage On | → Buy |
| 07/29/2019 | 292.52% | Keybanc | → $21 | Initiates Coverage On | → Sector Weight |
| 06/04/2019 | 273.83% | Loop Capital | → $20 | Initiates Coverage On | → Hold |
| 04/02/2019 | 348.6% | HSBC | $25 → $24 | Maintains | Hold |
| 12/12/2018 | 311.21% | HSBC | → $22 | Initiates Coverage On | → Hold |
| 10/31/2018 | — | Credit Suisse | Upgrades | Neutral → Outperform | |
| 10/08/2018 | 516.82% | Jefferies | → $33 | Initiates Coverage On | → Buy |
| 08/02/2018 | — | Goldman Sachs | Downgrades | Buy → Neutral | |
| 08/01/2018 | 666.36% | B of A Securities | $35.5 → $41 | Maintains | Neutral |
| 08/01/2018 | — | Credit Suisse | Downgrades | Outperform → Neutral |
What is the target price for iQIYI (IQ)?
The latest price target for iQIYI (NASDAQ: IQ) was reported by Macquarie on July 27, 2023. The analyst firm set a price target for $5.12 expecting IQ to fall to within 12 months (a possible -4.30% downside). 17 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for iQIYI (IQ)?
The latest analyst rating for iQIYI (NASDAQ: IQ) was provided by Macquarie, and iQIYI upgraded their neutral rating.
When is the next analyst rating going to be posted or updated for iQIYI (IQ)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of iQIYI, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for iQIYI was filed on July 27, 2023 so you should expect the next rating to be made available sometime around July 27, 2024.
Is the Analyst Rating iQIYI (IQ) correct?
While ratings are subjective and will change, the latest iQIYI (IQ) rating was a upgraded with a price target of $0.00 to $5.12. The current price iQIYI (IQ) is trading at is $5.35, which is out of the analyst's predicted range.